CTOs on the Move

SAB Biotherapeutics

www.sabbiotherapeutics.com

 
SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. SAB has applied advanced genetic engineering and antibody science to develop transchromosomic (Tc) Bovine™ herds that produce fully-human antibodies targeted at specific diseases, including infectious diseases such as COVID-19 and influenza, immune system disorders including type 1 diabetes and organ transplantation, and cancer. SAB`s versatile DiversitAb™ platform is appliable to a wide range of serious unmet needs in human diseases. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB is currently advancing multiple clinical programs and has a number ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Miller
Senior Director of Information Technology and Security Profile

Funding

SAB Biotherapeutics raised $22M on 12/20/2018
SAB Biotherapeutics raised $14M on 07/17/2020

Similar Companies

Triton Pharma

Triton Pharma Inc. is a Concord, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmaceutical Search Professionals Inc

Pharmaceutical Search Professionals Inc is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biomed International

Biomed International is a Burnaby, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gala Therapeutics

Gala Therapeutics is a medical devices company developing therapies to improve survival, quality of life, and outcomes for patients with pulmonary diseases.